BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32284737)

  • 1. The LncRNA HOTAIRM1 Promotes Tamoxifen Resistance by Mediating HOXA1 Expression in ER+ Breast Cancer Cells.
    Kim CY; Oh JH; Lee JY; Kim MH
    J Cancer; 2020; 11(12):3416-3423. PubMed ID: 32284737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
    Li Q; Dong C; Cui J; Wang Y; Hong X
    J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA HotairM1 Depletion Promotes Self-Renewal of Cancer Stem Cells through HOXA1-Nanog Regulation Loop.
    Li F; Xu Y; Xu X; Ge S; Zhang F; Zhang H; Fan X
    Mol Ther Nucleic Acids; 2020 Dec; 22():456-470. PubMed ID: 33230449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA HOTAIRM1/HOXA1 Axis Promotes Cell Proliferation, Migration And Invasion In Endometrial Cancer.
    Li X; Pang L; Yang Z; Liu J; Li W; Wang D
    Onco Targets Ther; 2019; 12():10997-11015. PubMed ID: 31853186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Non-Coding RNA HOXA Transcript Antisense RNA Myeloid-Specific 1-HOXA1 Axis Downregulates the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells in Lung Cancer.
    Tian X; Ma J; Wang T; Tian J; Zhang Y; Mao L; Xu H; Wang S
    Front Immunol; 2018; 9():473. PubMed ID: 29662483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A conserved
    Segal D; Coulombe S; Sim J; Dostie J
    RNA Biol; 2023 Jan; 20(1):1523-1539. PubMed ID: 37743644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA HOTAIRM1 promotes MDSC expansion and suppressive functions through the HOXA1-miR124 axis during HCV infection.
    Thakuri BKC; Zhang J; Zhao J; Nguyen LN; Nguyen LNT; Khanal S; Cao D; Dang X; Schank M; Wu XY; Morrison ZD; Gazzar ME; Li Z; Jiang Y; Ning S; Wang L; Moorman JP; Yao ZQ
    Sci Rep; 2020 Dec; 10(1):22033. PubMed ID: 33328510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA HOTAIRM1 promotes myeloid-derived suppressor cell expansion and suppressive functions through up-regulating HOXA1 expression during latent HIV infection.
    Zhang J; Thakuri BKC; Zhao J; Nguyen LN; Nguyen LNT; Cao D; Dang X; Khanal S; Schank M; Lu Z; Wu XY; Morrison ZD; Gazzar ME; Li Z; Jiang Y; Ning S; Wang L; Moorman JP; Yao ZQ
    AIDS; 2020 Dec; 34(15):2211-2221. PubMed ID: 33048872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. lncRNA HOTAIRM1 promotes osteogenesis of hDFSCs by epigenetically regulating HOXA2 via DNMT1 in vitro.
    Chen Z; Zheng J; Hong H; Chen D; Deng L; Zhang X; Ling J; Wu L
    J Cell Physiol; 2020 Nov; 235(11):8507-8519. PubMed ID: 32324272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of long noncoding RNA HOTAIRM1 promotes monocyte/dendritic cell differentiation through competitively binding to endogenous miR-3960.
    Xin J; Li J; Feng Y; Wang L; Zhang Y; Yang R
    Onco Targets Ther; 2017; 10():1307-1315. PubMed ID: 28280365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of the lncRNA HOTAIRM1 promotes lenvatinib resistance by downregulating miR-34a and activating autophagy in hepatocellular carcinoma.
    Gu D; Tong M; Wang J; Zhang B; Liu J; Song G; Zhu B
    Discov Oncol; 2023 May; 14(1):66. PubMed ID: 37171645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy.
    Wang J; Xie S; Yang J; Xiong H; Jia Y; Zhou Y; Chen Y; Ying X; Chen C; Ye C; Wang L; Zhou J
    J Hematol Oncol; 2019 Jul; 12(1):81. PubMed ID: 31340867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EZH2 inhibition sensitizes tamoxifen‑resistant breast cancer cells through cell cycle regulation.
    Chen S; Yao F; Xiao Q; Liu Q; Yang Y; Li X; Jiang G; Kuno T; Fang Y
    Mol Med Rep; 2018 Feb; 17(2):2642-2650. PubMed ID: 29207119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide analysis of the FOXA1 transcriptional regulatory network identifies super enhancer associated LncRNAs in tamoxifen resistance.
    Zhang X; Zhang Q; Liu G
    Front Genet; 2022; 13():992444. PubMed ID: 36204307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
    Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
    FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTA1 is a novel regulator of autophagy that induces tamoxifen resistance in breast cancer cells.
    Lee MH; Koh D; Na H; Ka NL; Kim S; Kim HJ; Hong S; Shin YK; Seong JK; Lee MO
    Autophagy; 2018; 14(5):812-824. PubMed ID: 29130361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA cluster.
    Zhang X; Lian Z; Padden C; Gerstein MB; Rozowsky J; Snyder M; Gingeras TR; Kapranov P; Weissman SM; Newburger PE
    Blood; 2009 Mar; 113(11):2526-34. PubMed ID: 19144990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H3K27me3 induces multidrug resistance in small cell lung cancer by affecting HOXA1 DNA methylation via regulation of the lncRNA HOTAIR.
    Fang S; Shen Y; Chen B; Wu Y; Jia L; Li Y; Zhu Y; Yan Y; Li M; Chen R; Guo L; Chen X; Chen Q
    Ann Transl Med; 2018 Nov; 6(22):440. PubMed ID: 30596070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA CYTOR promotes tamoxifen resistance in breast cancer cells via sponging miR‑125a‑5p.
    Liu Y; Li M; Yu H; Piao H
    Int J Mol Med; 2020 Feb; 45(2):497-509. PubMed ID: 31894257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells.
    Li F; Miao L; Xue T; Qin H; Mondal S; Thompson PR; Coonrod SA; Liu X; Zhang X
    J Exp Clin Cancer Res; 2019 Oct; 38(1):414. PubMed ID: 31601253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.